Skip to main content

Table 1 Patient demographic and clinical characteristics for younger (18–59 years) and older (60+ years) age at breast cancer diagnosis, California, 2005–2015

From: Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status

 

All

Younger (18–59)

Older (60+)

Total Number of Patients

192,932

100.0

94,076

100.0

98,856

100.0

Age (yrs) Mean (SD)

60.2(13.7)

48.8(7.3)

71.2(8.3)

Age category

 18–39

10,785

5.6

10,785

11.5

 40–49

35,297

18.3

35,297

37.5

 50–59

47,994

24.9

47,994

51.0

 60–69

49,225

25.5

49,225

49.8

 70–79

31,540

16.3

31,540

31.9

 80+

18,091

9.4

18,091

18.3

Race/ethnicity

 Non-Hispanic White

116,534

60.4

49,107

52.2

67,427

68.2

 Non-Hispanic Black

12,014

6.2

6348

6.7

5666

5.7

 Hispanic

36,363

18.8

22,305

23.7

14,058

14.2

 Asian/Pacific Islander

25,871

13.4

15,242

16.2

10,629

10.8

 Other/unknown

2150

1.1

1074

1.1

1076

1.1

Marital status

 Married

77,754

40.3

31,324

33.3

46,430

47.0

 Unmarried

107,808

55.9

59,344

63.1

48,464

49.0

 Unknown

7370

3.8

3408

3.6

3962

4.0

Neighborhood (block group) statewide SES quintile

 1st (lowest)

23,702

12.3

12,174

12.9

11,528

11.7

 2nd

33,174

17.2

15,787

16.8

17,387

17.6

 3rd

39,136

20.3

18,584

19.8

20,552

20.8

 4th

45,882

23.8

22,231

23.6

23,651

23.9

 5th (highest)

51,038

26.5

25,300

26.9

25,738

26.0

Insurance status

 Private only

112,154

58.1

71,611

76.1

40,543

41.0

 Medicare only or Medicare+Private

40,789

21.1

-a

-a

40,789

41.3

 Any Medicaid/Military/Other public

33,225

17.2

18,671

19.8

14,554

14.7

 No insurance

1598

0.8

1085

1.2

513

0.5

 Unknown

5166

2.7

2709

2.9

2457

2.5

National Cancer Institute-–designated cancer center

 No

170,509

88.4

80,161

85.2

90,348

91.4

 Yes

22,423

11.6

13,915

14.8

8508

8.6

AJCC Stage

 I

91,898

47.6

39,390

41.9

52,508

53.1

 II

68,825

35.7

36,785

39.1

32,040

32.4

 III

22,492

11.7

13,251

14.1

9241

9.3

 IV

7249

3.8

3609

3.8

3640

3.7

2468

1.3

1041

1.1

1427

1.4

Tumor subtype

 ER+, PR+/HER2-

125,240

64.9

56,822

60.4

68,418

69.2

 ER+, PR+//HER2+

19,630

10.2

11,808

12.6

7822

7.9

 ER-, PR−//HER2+

9023

4.7

5467

5.8

3556

3.6

 Triple negative

19,836

10.3

11,280

12.0

8556

8.7

 Unclassified

19,203

10.0

8699

9.2

10,504

10.6

Lymph node involvement

 Negative

126,915

65.8

56,446

60.0

70,469

71.3

 Positive

64,045

33.2

36,933

39.3

27,112

27.4

 Unknown

1972

1.0

697

0.7

1275

1.3

Tumor size (cm)

 0.10 ≤ tumor ≤0.50

13,488

7.0

6275

6.7

7213

7.3

 0.50 < tumor ≤1.00

31,342

16.2

12,706

13.5

18,636

18.9

 1.00 < tumor ≤2.00

67,792

35.1

31,674

33.7

36,118

36.5

 2.00 < tumor ≤5.00

64,694

33.5

34,472

36.6

30,222

30.6

 > 5.00

15,616

8.1

8949

9.5

6667

6.7

Grade

 Grade I

43,518

22.6

17,726

18.8

25,792

26.1

 Grade II

80,909

41.9

37,234

39.6

43,675

44.2

 Grade III/IV

61,205

31.7

35,688

37.9

25,517

25.8

 Unknown

7300

3.8

3428

3.6

3872

3.9

Histology

 Ductal

151,631

78.6

76,477

81.3

75,154

76.0

 Lobular

31,554

16.4

13,564

14.4

17,990

18.2

 Other

9747

5.1

4035

4.3

5712

5.8

  1. a Medicare-insured patients < 60 years of age were excluded